1. Nelson, J. D. The increasing frequency of β-lactamase-producingHaemophilus influenzae b. J. Am. Med. 244 (1980) 239–242.
2. Bégué, P., Floret, D., Mallet, E., Raynaud, E. J., Safran, C., Sarlangue, J., Teyssier, G. Pharmacokinetic and clinical evaluation of cefotaxime in children suffering with purulent meningitis. J. Antimicrob. Chemother. 14 (1984) 161–165.
3. Kenny, J. F., Isberg, C. D., Michaels, R. H. Meningitis due toHaemophilus influenzae type b resistant to both ampicillin and chloramphenicol. Pediatrics 66 (1980) 14–18.
4. Shelton, S., Nelson, J. D., McCracken, J. G. H. In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, RO 13-9904 and other cephalosporins. Antimicrob. Agents Chemother. 18 (1980) 476–479.
5. Bingen, E., Lambert-Zechovsky, N., Guihaire, E., Mariani, P., Coache, M., Jacqz, E., Aujard, Y., Mathieu, H. Intérêt de l'étude du temps minimal bactéricide du sérum dans le choix du traitement optimal des septicémies néonatales. Path. Biol. 35 (1987) 599–602.